Member Info for GUSTOS

Dahmed perfect storm here.News on a few fronts.New tax year.PIs filling isas and warrants coming to an end.Looks good matey

65.10 wti soaring

Looking better chaps.

Lazy;-)) Laxeys right the markets are dead at the moment.Hopefully if Nccl pull off a great RNS could put some fizz back into it.

Roll on end of tax year.These markets are terrible at present

Update due here.Won't be long expecting good news.

MMs must have read my post.;-))))

I should add DYOR,This is just an opinion

Well what am taking from it is.Right product right time,We sell are products but basically we have a product that many big guns will be after.Did he mention GE more than once.Watch this space even £1 a share is only £75m for the next generation of medical diagnosis.

Listen fellas.To me its simple.These yanks are mot soft and to give their company up for stock in another tells you one thing.Combined they are not expecting 4p 10p but a lot more.imo.The clues in the last two RNS.DYOR

Very bullish here.While reading between the lines

Lets hope she has sticky hands which I personally think she has.Hence the TR1 or otherwise why bother.

This lady.Dr. Kathleen Schmainda is Professor of Radiology and Vice-Chair of Radiology Research at the Medical College of Wisconsin (MCW). She received a BSE in Biomedical Engineering from Marquette University, a Masters in Electrical Engineering from the Massachusetts Institute of Technology (MIT) as well as a Ph.D. in Medical Engineering jointly awarded by MIT and Harvard University. After completing a fellowship at Massachusetts General Hospital she returned to the Midwest and MCW where she has been since.

Very surprising here at the moment but i agree will pop soon.Think they are expecting decent sales even to suggest a cash purchase.

Good deal imo.Opens up america

Phone them am with lloyds.

Whitey is that you.

Yes I wouldn't compare us to Hemo.We are basically a medical software company that is about to embark on first sales in a multimillion dollar niche medical area.Unlike most pharmas that have risen recently which need very costly and lengthy trials we are ready to go.Main market makes a big difference it means the bod are very confident.imo.DYOR

Hope that helps you establish why the main market is a safer bet.GL

When a company chooses to join the London Stock Exchange, it can list shares on the Main Market or seek admission to AIM. Companies listing on the Main Market have to satisfy certain regulatory criteria, providing audited statements for at least three years and being valued at £700,000 or more. Over 1500 companies are listed on the Main Market and some of the biggest are capitalised at more than £90 billion. AIM was created by the London Stock Exchange in 1995 to offer smaller companies the chance to raise money from outside investors. Since then over 3000 smaller, growing companies have joined AIM. Currently there are around 1450 companies on the market operating across 39 sectors in 100 countries.